Pretzel Therapeutics

A New Paradigm In Cellular Energetics

Waltham, United States · Founded 2022 · $131.8M raised

Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$131.8M
Last Round
$59.3M Venture RoundAug 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Pretzel Therapeutics is a clinical-stage biotech company developing small molecule therapies that target mitochondrial biology to treat metabolic diseases, rare mitochondrial disorders, and aging-related conditions. The company's lead program PX578 entered Phase 1 clinical trials in 2025, targeting POLRMT as a novel mechanism for metabolic disease treatment. Pretzel collaborates with leading research institutions including SciLifeLab to advance mitochondrial drug discovery.

Summary

Pretzel Therapeutics is a Biotech company based in Waltham, United States, founded in 2022. It has raised $131.8M in total across 2 rounds, most recently a $59.3M Venture Round in Aug 2024. Investors include ARCH Venture Partners, Mubadala Capital and HealthCap.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture UnknownAug 2024
$59.3M

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series BTotal funding$650.0MOct 2025
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$816.0MAug 2026
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate RoundTotal funding$730.0MDec 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Pretzel Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/pretzel-therapeutics"><img src="https://indexed.vc/api/badge/company/pretzel-therapeutics" alt="Pretzel Therapeutics on Indexed.vc" width="260" height="76" /></a>